Alexander Marshall Helfand

  • Pittsburgh, PA
  • Hematologist and oncologist
NPI1639525850PAC ID3375923097
Medicare services, 2024
231
Medicare patients, 2024
107
Part D claims, 2024
456
Publications
10
MIPS score, 2024
80
Practice address
4800 Friendship Avenue, Pittsburgh, PA 15224
Practice phone
Call (412) 578-5000
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

West Penn Hospital

Hospital · Pittsburgh, Pennsylvania

See all 8 affiliations

Find Alexander Helfand's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Alexander Marshall Helfand is a hematologist and oncologist in Pittsburgh, Pennsylvania

Alexander Helfand practices at West Penn Hospital in Pittsburgh, Pennsylvania, part of Highmark Health.

Alexander Helfand's NPI, 1639525850, was assigned on May 6, 2016. Alexander Helfand holds Pennsylvania license MD478309.

NPI and contact details
Medicare PAC ID
3375923097
NPI enumeration date
May 6, 2016
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Practice phone
(412) 578-5000
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
36
Medical school graduation
2016

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Alexander Marshall Helfand practices at West Penn Hospital in Pittsburgh, Pennsylvania

Alexander Helfand's primary practice is West Penn Hospital, at 4800 Friendship Avenue, Pittsburgh, PA 15224 in Allegheny County. The practice phone is (412) 578-5000.

  • West Penn Hospital
    4800 Friendship Avenue, Pittsburgh, PA 15224 · Allegheny CountyPhone(412) 578-5000

Source: Dmand AI Affiliation Data

Alexander Marshall Helfand is affiliated with 7 sites of care and 1 medical group

Alexander Helfand's primary practice is West Penn Hospital in Pittsburgh, Pennsylvania, part of Highmark Health. Alexander Helfand is also affiliated with Allegheny General Hospital. The medical group on file is Allegheny Health Network Cancer Institute. Dmand AI also links Alexander Helfand to 3 more hospitals, 1 group practice or clinic and 1 hospital outpatient department, each named with a free account.

See all 8 affiliations for Alexander Helfand

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Alexander Marshall Helfand's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Alexander Helfand practices, 7 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
West Penn HospitalAvailable with a free account
+6 more affiliated sitesAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Alexander Helfand practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across Highmark Health and 6.2K+ hospitals, with verified contacts in the same login.

Alexander Marshall Helfand is one of 645 hematologists and oncologists in Pennsylvania

Hematology and oncology is Alexander Helfand's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Alexander Helfand is licensed in Pennsylvania.

Specialties and state licenses

  • Hematology and oncology, PennsylvaniaPrimaryLicense MD478309 · taxonomy 207RH0003X

Hematologists and oncologists near Alexander Helfand

Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Alexander Marshall Helfand billed Medicare for 231 services in 2024

CMS data shows 231 Medicare services from Alexander Helfand across 5 procedure codes in 2024, for 107 Medicare patients. Medicare paid $17,415 for them.

Medicare services, 2024231
Medicare patients107
Paid by Medicare$17,415
Procedure codes5

Alexander Helfand's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Office and hospital visits
2023: 1732024: 1721%
Other services
2023: 02024: 59

Where Alexander Helfand's Medicare services took place, 2024

  • In an office16973%
  • In a facility6227%

Alexander Helfand compared with the Pennsylvania median for hematologists and oncologists, 2024

  • Alexander Helfand
  • Pennsylvania median
Medicare services
231vs 65465% below
Medicare patients
107vs 22753% below
Part D claims
297vs 39324% below

Medians across 600 hematologists and oncologists in Pennsylvania with Dmand AI profiles that report each measure.

Alexander Helfand's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Alexander Helfand

Need commercial claims for Alexander Helfand?

Medicare shows one payer. Book a meeting to get commercial claims data for Alexander Helfand and other hematologists and oncologists in Pennsylvania.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Alexander Marshall Helfand treated 107 Medicare patients in 2024, average age 72

CMS counts 107 Medicare patients who saw Alexander Helfand in 2024. The largest group is 65 to 74, with 57 patients. 75% of them have high blood pressure, and 71% have high cholesterol. Their average risk score is 2.34, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Alexander Helfand's median patient age at 71, with 23% women.

Medicare patients, 2024107
Average age72
Average risk score2.34

Alexander Helfand's Medicare patients by age, 2024

CMS leaves out age groups with fewer than 11 patients.

Alexander Helfand's Medicare patients by sex, 2024

  • Women3432%
  • Men7368%

Chronic conditions among Alexander Helfand's Medicare patients, 2024

  1. High blood pressure75%
  2. High cholesterol71%
  3. Cancer64%
  4. Arthritis37%
  5. Anxiety36%
  6. Chronic kidney disease36%
  7. Diabetes33%
  8. Ischemic heart disease32%

Share of Medicare patients with each condition. A patient can have several.

Alexander Helfand's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 71

Patient panel by sex, all payers

  • Women23%
  • Men78%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Alexander Marshall Helfand wrote 456 Medicare Part D claims in 2024

In 2024, Alexander Helfand wrote 456 Medicare Part D claims for 81 patients. 77% of them were for generic drugs. CMS names the drug for 297 of them, across 10 drugs with 11 or more claims each, at $722,933 in total drug cost. In 2023, CMS named 86 claims across 5 drugs.

Part D claims, 2024456
Drugs named by CMS10
Total drug cost$722,933
Part D patients81

Alexander Helfand's Part D claims by kind of drug, 2024

  • Generic351 claims77%
  • Brand-name105 claims23%

Alexander Helfand's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Alexander Helfand's Part D claims, 2024

  • Opioids2%11 of 456 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 862024: 297245%

Drugs named by CMS: 10 in 2024, 5 in 2023.

See all prescribing by Alexander Helfand

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Alexander Marshall Helfand scored 80 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Alexander Helfand for performance year 2024, reported as part of a group. Alexander Helfand accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Alexander Helfand as offering telehealth.

Accepts Medicare assignment
Yes
Offers telehealth
Yes

Alexander Helfand's MIPS scores, performance year 2024

  • 80of 100Final score
  • 73.4of 100Quality
  • 100of 100Promoting Interoperability
  • 40of 100Improvement Activities
  • 48of 100Cost

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find hematologists and oncologists like Alexander Helfand by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Alexander Marshall Helfand has 10 publications on record

Dmand AI links 10 papers to Alexander Helfand, published from 2011 to 2018. 2015 was the busiest year, with 5. The most frequent topics are Cystectomy, Kidney Failure, Chronic and Postoperative Complications. Alexander Helfand's most frequent co-authors are Rebekah Justine Beach, MD, Miriam Hadj-Moussa, MD and Khaled Samir Hafez, MBCHB.

Papers10
Years published2011 to 2018

Alexander Helfand's papers by year, 2011 to 2018

Topics Alexander Helfand writes about most

  • Cystectomy
  • Kidney Failure, Chronic
  • Postoperative Complications
  • Renal Insufficiency, Chronic
  • Urinary Bladder Neoplasms

Alexander Helfand's most frequent co-authors

Recent publications by Alexander Helfand

See all 10 publications and co-authors

See who Alexander Helfand researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Alexander Helfand works with, so you can find a warm path to the right hematologists and oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Alexander Marshall Helfand received $12,503 in industry payments from 2021 to 2025

CMS Open Payments shows 48 general payments to Alexander Helfand from 14 drug and device companies from 2021 to 2025. Consulting fees make up the largest share, 44% of the total. Bayer HealthCare Pharmaceuticals Inc. paid the most, $5,054.

General payments to Alexander Helfand by program year, 2021 to 2025

General payments to Alexander Helfand by kind, 2021 to 2025

$12.5Kin total
  • Consulting fees$5,46044%
  • Food and beverage$2,60521%
  • Travel and lodging$2,46120%
  • Honoraria$1,97816%

Companies that paid Alexander Helfand the most, 2021 to 2025

Share is of all general payments to this clinician.

See all payments to Alexander Helfand

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Sources for Alexander Marshall Helfand's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Industry paymentsOpen Payments (CMS) (opens in a new tab)
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Alexander Marshall Helfand

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Alexander Marshall Helfand's NPI number?

Alexander Marshall Helfand's NPI number is 1639525850. It was assigned on May 6, 2016, and it is active in the NPI Registry.

What does Alexander Marshall Helfand specialize in?

Alexander Marshall Helfand is a hematologist and oncologist in Pittsburgh, Pennsylvania. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).

Where does Alexander Marshall Helfand practice?

Alexander Helfand practices at 4800 Friendship Avenue, Pittsburgh, PA 15224. Alexander Helfand's primary practice is West Penn Hospital in Pittsburgh, Pennsylvania, part of Highmark Health. Dmand AI also links Alexander Helfand to 3 hospitals, 1 group practice or clinic and 1 hospital outpatient department.

What is Alexander Marshall Helfand's office phone number?

The practice phone on file for Alexander Helfand is (412) 578-5000.

What is Alexander Marshall Helfand's medical license number?

Alexander Helfand holds Pennsylvania license MD478309.

Which hospitals is Alexander Marshall Helfand affiliated with?

Alexander Helfand practices at West Penn Hospital in Pittsburgh, Pennsylvania. Alexander Helfand is also affiliated with Allegheny General Hospital. Dmand AI links Alexander Helfand to 3 more hospitals.

What medical group is Alexander Marshall Helfand part of?

Alexander Helfand is linked to Allegheny Health Network Cancer Institute.

Does Alexander Marshall Helfand accept Medicare?

Yes. CMS data shows Alexander Helfand billed Medicare for 231 services in 2024, and Alexander Helfand accepts Medicare assignment.

Does Alexander Marshall Helfand offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Alexander Helfand as offering telehealth services.

What is Alexander Marshall Helfand's MIPS score?

Alexander Helfand's MIPS final score for performance year 2024 is 80 out of 100, reported as part of a group.

Show 7 more questionsShow fewer questions

How many Medicare patients does Alexander Marshall Helfand see?

CMS counts 107 Medicare patients who saw Alexander Helfand in 2024, with an average age of 72.

What services does Alexander Marshall Helfand bill to Medicare?

In 2024, Alexander Helfand's most billed Medicare services were office visit, established patient (99215), medicare service (G2211) and office visit, established patient (99214).

What drugs does Alexander Marshall Helfand prescribe most?

In 2024 Medicare Part D data, Alexander Helfand's most prescribed drugs by claims were Prednisone, Abiraterone Acetate and Levothyroxine Sodium.

Has Alexander Marshall Helfand received payments from drug or device companies?

CMS Open Payments shows $12,503 in general payments to Alexander Helfand from 14 companies from 2021 to 2025. The largest total came from Bayer HealthCare Pharmaceuticals Inc.

How long has Alexander Marshall Helfand been practicing?

Alexander Helfand graduated from medical school in 2016, 10 years ago.

Does Alexander Marshall Helfand do research?

Dmand AI links 10 publications to Alexander Helfand, published from 2011 to 2018.

Who does Alexander Marshall Helfand publish with?

Alexander Helfand's most frequent co-authors are Rebekah Justine Beach, MD (1 shared paper), Miriam Hadj-Moussa, MD (1 shared paper) and Khaled Samir Hafez, MBCHB (1 shared paper).

Selling to hematology and oncology practices?

See hematologists and oncologists in Pennsylvania by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)